Senseonics Collaborating With Diasend on Integrated Continuous Glucose Data Management

Senseonics has signed an agreement with Diasend to integrate the Eversense continuous glucose monitoring system with the diasend Clinic and diasend Personal solutions.

Under the deal, the two companies will work together to enable clinicians and patients to use the diasend solution to review past Eversense continuous glucose monitoring data, along with insulin pump and activity tracker data.

Senseonics is developing Eversense as a long-term implantable system to measure glucose levels in diabetic patients for up to 90 days, while the diasend solutions allow users to review glucose reports in familiar and unified formats. — Jonathon Shacat